| Financial Year |
March 31 2023 |
| Monetary Funds |
704,214,522.16 |
| Held-for-trading Financial Assets |
330,725.59 |
| Notes Receivable |
-- |
| Accounts Receivable |
87,508,050.97 |
| Advances to Suppliers |
297,686,774.96 |
| Other Receivables |
250,675,316.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
9,463,631,438.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
674,819,715.19 |
| Total Current Assets |
11,478,866,543.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,225,757,201.54 |
| Investment Properties |
648,634,074.83 |
| Fixed Assetes |
819,309,244.01 |
| Under-construction Projects |
3,347,234.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
392,504,404.28 |
| R&D expenses |
-- |
| Goodwill |
189,295,321.60 |
| Long-Term Deferred and Prepaid Expenses |
161,325,390.82 |
| Deferred Income Tax Assets |
101,166,963.52 |
| Other Non-Current Assets |
62,231,076.01 |
| Sub-Total of Non-Current Assets |
3,642,167,719.86 |
| Total Assets |
15,121,034,263.72 |
| Short-Term Loans |
689,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,438,806,505.27 |
| Accounts Received In Advance |
12,557,453.24 |
| Employee Compensation Payable |
5,797,480.92 |
| Taxes Payable |
571,097,751.88 |
| Interest Payable |
-- |
| Dividend Payable |
709,126.59 |
| Other payables |
432,568,844.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
561,926,904.49 |
| Other Current Liabilities |
59,535,179.03 |
| Sub-Total of Current Liabilities |
4,462,169,761.22 |
| Long-term Loans |
709,200,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
20,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,073,950.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
753,164,880.57 |
| Total Liabilities |
5,215,334,641.79 |
| Paid-In Capital(Or Share Stock) |
3,034,636,384.00 |
| Capital Surplus |
605,783,888.26 |
| Surplus Reserve |
917,503,741.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,061,027,567.57 |
| Minority Stockholder's Interest |
273,076,646.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,632,622,975.07 |
| Owner's Equity（Stockholder's Equity） |
9,905,699,621.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,121,034,263.72 |
